Cargando…
The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson’s disease
BACKGROUND/AIMS: Since the degeneration of the nigrostriatal dopaminergic pathway in Parkinson’s disease (PD) is associated with the inflammation process and decreased levels of cyclic nucleotides, inhibition of up-regulated cyclic nucleotide phosphodiesterases (PDEs) appears to be a promising thera...
Autores principales: | Schwenkgrub, Joanna, Zaremba, Malgorzata, Joniec-Maciejak, Ilona, Cudna, Agnieszka, Mirowska-Guzel, Dagmara, Kurkowska-Jastrzębska, Iwona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533435/ https://www.ncbi.nlm.nih.gov/pubmed/28753652 http://dx.doi.org/10.1371/journal.pone.0182019 |
Ejemplares similares
-
Effects of α-Synuclein Monomers Administration in the Gigantocellular Reticular Nucleus on Neurotransmission in Mouse Model
por: Joniec-Maciejak, Ilona, et al.
Publicado: (2019) -
Deficiency of Biogenic Amines Modulates the Activity of Hypoglossal Nerve in the Reserpine Model of Parkinson’s Disease
por: Jampolska, Monika, et al.
Publicado: (2021) -
Sirtuin 1, Visfatin and IL-27 Serum Levels of Type 1 Diabetic Females in Relation to Cardiovascular Parameters and Autoimmune Thyroid Disease
por: Łukawska-Tatarczuk, Magdalena, et al.
Publicado: (2021) -
Blood-Brain Barrier-Associated Proteins Are Elevated in Serum of Epilepsy Patients
por: Bronisz, Elżbieta, et al.
Publicado: (2023) -
Serum Proteins Associated with Blood–Brain Barrier as Potential Biomarkers for Seizure Prediction
por: Bronisz, Elżbieta, et al.
Publicado: (2022)